Does intensive treatment targeting a systolic blood pressure of less than 120 mm Hg improve patient-reported outcomes compared to standard treatment?
Intensive blood pressure lowering to <120 mm Hg does not negatively impact patient-reported outcomes compared to standard treatment, even in patients with decreased physical or cognitive function.
Patient-reported outcomes among participants who received intensive treatment, which targeted a systolic blood pressure of less than 120 mm Hg, were similar to those among participants who received standard treatment, including among participants with decreased physical or cognitive function. (Funded by the National Institutes of Health; SPRINT ClinicalTrials.gov number, NCT01206062 .).
Berlowitz et al. (Wed,) studied this question.